Benitec Biopharma Inc
Benitec Biopharma Inc (BNTC) Implied Volatility Current
BNTC's 30 day implied volatility is 207.94%, with an IV Rank of 73.81%. This is a high IV Rank versus the past year, meaning Benitec Biopharma Inc options are relatively expensive and currently favor sellers. BNTC's 30 day historical volatility sits at 70.56%, which means implied volatility is running 137.38 points above historical volatility, as of Nov 16, 2026.
Read more
Tracking BNTC implied volatility helps you spot when Benitec Biopharma Inc options are historically cheap or expensive, and where the best trades are hiding. When BNTC IV rises, premiums increase and sellers get more attractive pricing, and when it drops, buyers find cheaper contracts. Use our scanner to monitor BNTC implied volatility current levels in real time and filter for high probability trades.
Implied volatility is derived from option prices and represents the annualized expected move of a stock. Tracking BNTC IV rank helps you see whether BNTC's implied volatility is historically high or low, since IV rank compares today's reading against the past year's range. A high rank signals relatively expensive premiums and tends to favor sellers, a low rank signals relatively cheap premiums and tends to favor buyers.
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.
Implied Volatility
IV is highly elevated. Premiums are expensive, strongly favoring sellers.
As of Nov 16, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →